지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
등록된 정보가 없습니다.
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
Lymphocyte-Activation Gene-3 Expression and Prognostic Value in Neoadjuvant-Treated Triple-Negative Breast Cancer
Journal of Breast Cancer
2018 .01
Neoadjuvant chemotherapy followed by surgery has no therapeutic advantages over concurrent chemoradiotherapy in International Federation of Gynecology and Obstetrics stage IB-IIB cervical cancer
Journal of Gynecologic Oncology
2016 .01
Oncologic Outcomes of Immediate Breast Reconstruction in the Setting of Neoadjuvant Chemotherapy: A Long-term Follow-up Study of a Matched Cohort
Journal of Breast Cancer
2024 .02
Significant clinicopathologic prognostic factors for bladder recurrence, progression, and cancer-specific survival after surgery among patients with upper urinary tract urothelial carcinoma
Investigative and Clinical Urology
2019 .01
호르몬 수용체 약양성 유방암과 삼중음성 유방암의 치료 예후
Journal of Breast Disease
2019 .01
Study of neoadjuvant chemotherapy in advanced malignant ovarian germ cell tumors at a tertiary center in western India
Journal of Gynecologic Oncology
2024 .03
Effect of Platinum-Based Chemotherapy on PD-L1 Expression on Tumor Cells in Non-small Cell Lung Cancer
Cancer Research and Treatment
2019 .01
Higher Non-High-Density Lipoprotein Cholesterol Was Higher Associated With Cardiovascular Disease Comparing Higher LDL-C in Nine Years Follow Up: Cohort Study
지질·동맥경화학회지
2023 .05
Impact of diabetes mellitus on morbidity and survival after pancreaticoduodenectomy for malignancy
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .05
Identification of Significant Prognostic Tissue Markers Associated with Survival in Upper Urinary Tract Urothelial Carcinoma Patients Treated with Radical Nephroureterectomy: A Retrospective Immunohistochemical Analysis Using Tissue Microarray
Cancer Research and Treatment
2020 .01
Predictive Value of IHC4 Score for Pathological Response to Neoadjuvant Chemotherapy in Hormone Receptor-Positive Breast Cancer
Asian Pacific journal of cancer prevention : APJCP
2015 .01
Partial Virological Response after 2 Years of Entecavir Therapy Increases the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Virus-Associated Cirrhosis
Gut and Liver
2021 .01
Blood Pressure and the Risk of Death From Non-cardiovascular Diseases: A Population-based Cohort Study of Korean Adults
예방의학회지
2018 .01
Analysis of risk factors associated with survival in human epidermal growth factor receptor 2-positive ductal carcinoma in situ using Korean Breast Cancer Society Database
Annals of Surgical Treatment and Research
2021 .12
Prognostic Factors for Distant Metastasis in Patients with Loco-regional Recurrence after Mastectomy
Journal of Breast Cancer
2015 .01
Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial
Cancer Research and Treatment
2019 .01
Predicting the Response of Neoadjuvant Chemotherapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer With Axillary Lymph Node Metastasis by Multigene Assay
Journal of Breast Cancer
2022 .12
Heart Rate Responses at Rest, during Exercise and after Exercise Periods in Relation to Adiposity Levels among Young Nigerian Adults
Journal of Obesity & Metabolic Syndrome
2023 .03
Improving the efficacy and safety of concurrent chemoradiotherapy by neoadjuvant chemotherapy: a randomized controlled study of locally advanced cervical cancer with a large tumor
Journal of Gynecologic Oncology
2024 .01
Tumor-Infiltrating Lymphocytes in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Neoadjuvant Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab
Journal of Breast Cancer
2021 .08
0